The Power of Your Choice
Your choice of the IHTC Pharmacy Program directly supports your IHTC team and patient services, and activities provided to the hemophilia community. The IHTC Pharmacy Program provides savings to you and your health insurance plan.
Every patient has the right to choose their clotting factor pharmacy provider. The IHTC supports your right of choice and will assist you in making an informed decision.
Sickle Cell Disease Resources
The IHTC is involved a variety of research studies to better understand the complications of sickle cell disease. It is our hope that this research will allow the medical community at large to develop treatments to prevent or minimize complications, prolong and improve the quality of life for those with sickle cell disease. Through the IHTC, patients have access to national multicenter studies.
If you are interested in participating in a research study, please let a member of our healthcare team know.
IHTC currently has no active research studies enrolling patients. Please check the website often, we will be enrolling patients for future studies soon!